Clinical Trials and Publications
Please select a tab below to view either Aqua Medical sponsored studies or published articles about our technology.
To sort this list by title, publication year or author, simply click on the corresponding column header.
| Title | Publication | Month | Year | Author |
|---|
Welcome to the Aqua Medical Clinical Trials page where you will find information on studies sponsored by Aqua Medical, Inc. and registered on www.clinicaltrials.gov.
Clinical trials are a vital part of our research and continued evolution of Aqua Medical’s technological innovations.
You can learn more about these studies below or by going to the respective study record page on clincaltrials.gov.
Safety, Tolerability, and Effectiveness of Duodenal Mucosal RF Vapor Ablation for Insulin Elimination in Type-2 Diabetes (STEAM-IE)
The purpose of this study is to determine whether RFVA of the duodenal mucosa with or without the combination of Semaglutide is a safe and effective treatment to remove the need for insulin therapy among patients with T2D who are on stable doses of insulin.
ID# NCT06655740
A Pilot Human Investigation of the Safety, Tolerability and Effectiveness of the Aqua Medical Circumferential RF Vapor (RFV) Ablation System for Duodenal Mucosal Ablation for the Management of Type-2 Diabetes Mellitus (STEAM T-2DM Pilot)
The purpose of this clinical study is to test the hypothesis that RF vapor ablation of the duodenal mucosa will result in improvement in glycemic parameters, without complications (bleeding/ stricture / perforation).
ID# NCT05887635
Be the first to know
as Aqua Medical continues key research, gains additional regulatory clearances for its RFVA platform components, and shares new peer-reviewed clinical publications.